Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by CerealKilleron Feb 06, 2021 8:51pm
141 Views
Post# 32494532

RE:RE:Modivolve is marking real progress backed by revenue numbers

RE:RE:Modivolve is marking real progress backed by revenue numbers
maidenmist wrote: And the mystery continues. What about cannacord covering this stock or at least initiate coverage of the stock cone April. This company is making money. Others in the same field are not. Yet SONA is triple the share price. We can't even post a link on this board with respect to the webinar. And we're suppose to buy based on a kid in his basement pumping MEDV and calling it a 48 dollar stock. Add credibility by perhaps an analyst on BNN


Oh you and SONA, SONA, SONA, SONA... When are you going to get it through your head that it's not going to do what SONA did, and there's no reasonable reason for it to do so either.
<< Previous
Bullboard Posts
Next >>